1297 related articles for article (PubMed ID: 22951651)
1. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
[TBL] [Abstract][Full Text] [Related]
3. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates.
Lin SP; Liu MF; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
[TBL] [Abstract][Full Text] [Related]
6. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran.
Jabalameli F; Mirsalehian A; Sotoudeh N; Jabalameli L; Aligholi M; Khoramian B; Taherikalani M; Emaneini M
Burns; 2011 Nov; 37(7):1202-7. PubMed ID: 21703769
[TBL] [Abstract][Full Text] [Related]
7. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
[TBL] [Abstract][Full Text] [Related]
8. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
10. Spread of extended-spectrum β-lactamase genes of blaOXA-10, blaPER-1 and blaCTX-M in Pseudomonas aeruginosa strains isolated from burn patients.
Farshadzadeh Z; Khosravi AD; Alavi SM; Parhizgari N; Hoveizavi H
Burns; 2014 Dec; 40(8):1575-80. PubMed ID: 24767142
[TBL] [Abstract][Full Text] [Related]
11. PER-1- and OXA-10-like beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey.
Aktaş Z; Poirel L; Salcioğlu M; Ozcan PE; Midilli K; Bal C; Anğ O; Nordmann P
Clin Microbiol Infect; 2005 Mar; 11(3):193-8. PubMed ID: 15715716
[TBL] [Abstract][Full Text] [Related]
12. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
Mirsalehian A; Feizabadi M; Nakhjavani FA; Jabalameli F; Goli H; Kalantari N
Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea.
Lee S; Park YJ; Kim M; Lee HK; Han K; Kang CS; Kang MW
J Antimicrob Chemother; 2005 Jul; 56(1):122-7. PubMed ID: 15890715
[TBL] [Abstract][Full Text] [Related]
14. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
[TBL] [Abstract][Full Text] [Related]
15. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
19. [Metallo-beta-lactamase-mediated resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates].
Mereuţă AI; Tuchiluş C; Bădescu AC; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1208-13. PubMed ID: 22276471
[TBL] [Abstract][Full Text] [Related]
20. Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
Strateva T; Ouzounova-Raykova V; Markova B; Todorova A; Marteva-Proevska Y; Mitov I
J Chemother; 2007 Apr; 19(2):140-5. PubMed ID: 17434821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]